Table: SymBio Pharmaceuticals - Q1 parent results

SymBio Pharmaceuticals

13/05/2021 07:30

May 13 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2021        Mar 31, 2020     Dec 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             1.42               551 mln           9.15     
                (+157.6 pct)         (-65.8 pct)     (+206.4 pct) 
  Operating     loss 210 mln        loss 961 mln         1.36     
  Recurring     loss 208 mln        loss 991 mln         1.35     
  Net           loss 209 mln        loss 992 mln         1.15     
  EPS           loss 5.49 yen      loss 35.84 yen      30.08 yen  
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T